Association between longitudinal weight change and clinical outcome in individuals with MASLD.
In a longitudinal cohort of 10,014 people, weight gain above 5% was associated with higher risks of liver-related events and liver-stiffness progression.
PUBLICATIONS / 发表成果
Publications involving our team across author positions. Browse by year, topic, or author role.
143 publications
In a longitudinal cohort of 10,014 people, weight gain above 5% was associated with higher risks of liver-related events and liver-stiffness progression.
In an observational cohort of 7,867 people across 16 centers, SGLT-2 inhibitor use was associated with lower risks of liver-related events and liver-stiffness progression.
Single-cell and spatial transcriptomics with experimental validation identified the ANXA1–FPR1 resolution axis; Ac2-26 reduced inflammation and liver injury in preclinical models.